BMY built a nice base today in a down market.

[anonymous]

Hopefully it will stay above 50 and find its way back above 60 real soon. Does anyone have a guess for what price BMY could/will get in a buyout?

 

[anonymous]

Hopefully it will stay above 50 and find its way back above 60 real soon. Does anyone have a guess for what price BMY could/will get in a buyout?

BMY is at 48 and taking on water. The best play is to short the stock. Takeover is unlikely.

Here is some due diligence. No charge.

Our recent survey with 31 oncologists across the U.S. supports our cautious views on BMY’s IO franchise. 4Q16 should be O.K. as the IO franchise will likely beat because the Street is missing ex-US deferred revenue, but the focus remains on longer term outlook. 2017 EPS guidance could be lowered to account for Non-Small Cell Lung Cancer Treatment competitive dynamics and 3-5% Fx headwind. With ongoing setbacks in IO, we see increased execution risk. Given increased uncertainty about the potential of the IO franchise, we think a takeout/merger is less likely. We remain cautious.